Summit Therapeutics Inc. (SMMT) Net margin 2017–2022
Summit Therapeutics Inc. (SMMT) net profit margin by fiscal year — reported net income divided by reported revenue.
-11174.8%FY2022 · since FY2017: -163.6% → -11174.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -11174.8% | -6276.9 pp |
| FY2021 | -4897.8% | +1229.7 pp |
| FY2020 | -6127.6% | — |
| FY2018 | 19.0% | +182.7 pp |
| FY2017 | -163.6% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More SMMT financial trends
SMMT RevenueSMMT Net incomeSMMT Gross profitSMMT Gross marginSMMT Operating incomeSMMT Operating marginSMMT Operating cash flowSMMT Free cash flowSMMT Capital expendituresSMMT Return on equitySMMT Stock buybacksSMMT Dividends paidSMMT Total assetsSMMT Total liabilitiesSMMT Shareholders’ equitySMMT overview →